Hemodynamic and Biological Evaluations During Reventilation Collapse in ICU

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01785654

Acronym

REVECOL

Enrollment

400

Registered

2013-02-07

Start date

2013-03-31

Completion date

2014-12-31

Last updated

2013-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Patients, Arterial Line, Consent of Patients, Tracheal Intubation in ICU

Keywords

Reventilation collapse, Rate of reventilation collapse, Risk factor of reventilation collapse, Hemodynamic profile of reventilation collapse, Biologic approach of reventilation collapse

Brief summary

Prospective, observational clinical multicentric study in ICU; during the period surrounding the orotracheal intubation.

Detailed description

Main objective: to describe the characteristics of reventilation collapse: collapse rate, duration and treatment implemented Secondary objectives: * identify risk factors of reventilation collapse * compare mortality, hemodynamic, respiratory, infectious and biological data between collapse group and no reventilation collapse group.

Interventions

None listed

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Arterial line * Consent of patients * Adult patients * Tracheal intubation in ICU

Exclusion criteria

* tracheal intubation for cardiac arrest * pregnant woman * major protected

Design outcomes

Primary

Measure	Time frame
Reventilation collapse	at day 1 (at least thirty minutes despite 500 or 1000ml of fluid resuscitation)

Secondary

Measure	Time frame
reventilation collapse	in the last 72 hours
Duration of mechanical ventilation	at day 1
mortality	at day 28

Countries

France

Contacts

Primary ContactPatrick LACARIN

placarin@chu-clermontferrand.fr04 73 75 11 95

Outcome results